| Name | long intergenic non-protein coding RNA 861 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n LINC00861 has emerged as a multifunctional long non‐coding RNA that appears to play diverse roles in human disease by modulating gene expression and influencing key signaling pathways. In cervical cancer, reduced expression of LINC00861 is associated with advanced disease stage, lymph node metastasis, and poor patient survival. Functional studies demonstrated that its overexpression suppresses cell proliferation, migration, invasion, and epithelial–mesenchymal transition through acting as a competing endogenous RNA that sponges miR‐513b‑5p, thereby upregulating PTEN and subsequently inhibiting the AKT/mTOR pathway."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition, genetic studies in eczema have identified novel common variants at the TRIB1/LINC00861 locus, implicating LINC00861 in the regulation of skin barrier function and/or immune responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Similarly, in non‐smoking chronic obstructive pulmonary disease, LINC00861 participates in a regulatory network with microRNAs and transcription factors, suggesting a role in modulating pulmonary inflammatory processes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n LINC00861 has also been identified as a prognostic biomarker in ovarian cancer, where its copy number variation and expression status correlate with patient outcomes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " In Parkinson’s disease, alterations in LINC00861 expression within an lncRNA–mRNA co‐expression network point to an involvement in regulating immune responses, which may contribute to disease pathogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In hepatocellular carcinoma, LINC00861 is included in DNA repair–associated and early recurrence prognostic signatures, suggesting that its deregulation may influence cell cycle processes and tumor aggressiveness"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Finally, integrative analyses in breast cancer have revealed that LINC00861 may interact with established clinical biomarkers such as estrogen and progesterone receptors and receptor tyrosine‐protein kinase erbB‑2, thereby implicating it in the transcriptional regulatory networks that govern tumor behavior."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Taken together, these studies reveal that LINC00861 appears to function predominantly as a tumor suppressor or prognostic marker by modulating cell signaling pathways—including the PTEN/AKT/mTOR axis—and by participating in gene regulatory networks involved in immune response and cellular stress, with its dysregulation being associated with poor clinical outcomes across a range of diseases.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Hui Liu, Ling Zhang, Xiaoling Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2020.11662"}], "href": "https://doi.org/10.3892/mmr.2020.11662"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33179755"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33179755"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Sarah Grosche, Ingo Marenholz, Jorge Esparza-Gordillo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-021-26783-x"}], "href": "https://doi.org/10.1038/s41467-021-26783-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34785669"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34785669"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yan Qian, Zheng-Dao Mao, Yu-Jia Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive Analysis of miRNA-mRNA-lncRNA Networks in Non-Smoking and Smoking Patients with Chronic Obstructive Pulmonary Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000494541"}], "href": "https://doi.org/10.1159/000494541"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30355907"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30355907"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Mingjun Zheng, Yuexin Hu, Rui Gou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109810"}], "href": "https://doi.org/10.1016/j.biopha.2019.109810"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32000042"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32000042"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kecheng Lei, Liwen Zhang, Yijing He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immune-associated biomarkers for early diagnosis of Parkinson's disease based on hematological lncRNA-mRNA co-expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20202921"}], "href": "https://doi.org/10.1042/BSR20202921"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33245101"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33245101"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Hanyi Zeng, Chengdong Liu, Xiaohan Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A New Prognostic Strategy Based on four DNA Repair-Associated lncRNAs for Hepatocellular Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Comb Chem High Throughput Screen (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/1386207324666210302091432"}], "href": "https://doi.org/10.2174/1386207324666210302091432"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33653241"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33653241"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yufeng Lv, Wenhao Wei, Zhong Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA expression profile can predict early recurrence in hepatocellular carcinoma after curative resection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatol Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/hepr.13220"}], "href": "https://doi.org/10.1111/hepr.13220"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29924905"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29924905"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yuhan Zhang, Yongfeng Li, Qing Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of an lncRNA‑miRNA‑mRNA interaction mechanism in breast cancer based on bioinformatic analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2017.7304"}], "href": "https://doi.org/10.3892/mmr.2017.7304"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28849135"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28849135"}]}]}]}
|
| NCBI Gene ID | 100130231 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LINC00861 has 690 functional associations with biological entities spanning 2 categories (cell line, cell type or tissue, gene, protein or microRNA) extracted from 8 datasets.
Click the + buttons to view associations for LINC00861 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00861 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00861 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of LINC00861 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of LINC00861 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of LINC00861 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with LINC00861 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00861 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of LINC00861 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |